title: A preliminary economic evaluation of percutaneous neuromuscular electrical stimulation in the treatment of hemiplegic shoulder pain.
abstract: OBJECTIVE
  The objective of this study was to compare the cost-effectiveness of various treatment modalities for hemiplegic shoulder pain.
  
  
  METHODS
  A stage II economic evaluation.
  
  
  METHODS
  Incremental cost effectiveness ratio of P-NMES, compared to slings and anti-inflammatory injections.
  
  
  RESULTS
  The incremental cost effectiveness ratio (ICER) of p-NMES, compared to anti-inflammatory injections is 6,061 euro(+/-3,285). The incremental cost of the first quality-adjusted life year after implantation of the P-NMES device compared to anti-inflammatory injections is 33,007 euro (+/-5,434). This decreases to approximately 7,000 euro after 5 years, and to approximately 5,000 euro after 10 survival years.
  
  
  CONCLUSIONS
  In this early evaluation, P-NMES seems to be cost-effective according to known guidelines. Treatment with P-NMES is recommended for patients with chronic HSP.
authors.affiliation: Roessingh Research and Development, Enschede, The Netherlands. j.vantil@rrd.nl
authors.forename: Janine A
authors.initials: JA
authors.lastname: Van Til
authors.forename: Gerbert J
authors.initials: GJ
authors.lastname: Renzenbrink
authors.forename: Karin
authors.initials: K
authors.lastname: Groothuis
authors.forename: Maarten J
authors.initials: MJ
authors.lastname: Ijzerman
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000191:economics / Q000627:therapeutic use; D002908:Chronic Disease; D003362:Cost-Benefit Analysis; D004180:Direct Service Costs; D004599:Electric Stimulation Therapy / Q000191:economics* / Q000379:methods; D004567:Electrodes, Implanted; D006429:Hemiplegia / Q000150:complications / Q000191:economics / Q000534:rehabilitation*; D006801:Humans; D017059:Models, Econometric; D009426:Netherlands; D019057:Quality-Adjusted Life Years; D012149:Restraint, Physical; D020069:Shoulder Pain / Q000191:economics / Q000209:etiology / Q000628:therapy*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal